How we score →

Ro vs. PlushCare

✓ Updated July 2026 GLP-1 weight care: cash-pay vs. insurance-first.
Advertising Disclosure: TelehealthIndex is reader-supported. If you sign up with a provider through links on this page, we may earn a commission at no extra cost to you. Commissions never influence our scores or rankings — several of our top-rated providers pay us nothing. How we score → · Full disclosure →
69.1/100Good
Ro
Good · #2 in Men's Health (ED & TRT)
Visit Ro Read full review
65.5/100Good
PlushCare
Good · #5 in Weight Loss & GLP-1 Medications
Visit PlushCare Read full review
Our read: Under our 100-point methodology, Ro scores 69.1/100 and PlushCare scores 65.5/100 — so Ro ranks higher in our assessment. Scores are editorial opinions, not a factual ranking of the companies themselves; the right fit depends on how you pay and what you need — see the breakdown below.
FactorRoPlushCare
Clinical credibility Limited Weak
Regulatory & safety record Minor deductions Minor deductions
Transparency & trust Good Mixed
Access & coverage Good Exceptional
Customer experience Good Good
Value & pricing Mixed Weak
Factor ratings are qualitative summaries of our internal rubric — we do not publish the point weights. Highlighted = the higher-rated provider on that factor.

TelehealthIndex scores and rankings are editorial opinions resulting from our selection, weighting, and interpretation of the factors described in our methodology.

Choose Ro if…

  • clinical depth is your priority

Choose PlushCare if…

  • you want to use insurance
 RoPlushCare
PricingWeight membership from $74/mo + meds at LillyDirect/NovoCare-matched prices; ED from $4/dose; hair from $16/mo$19.99/mo membership + ~$30 insured visit or $129 cash; weight program via primary care
InsurancePartialYes
Availability49 statesNationwide
Money-backNot advertisedNot advertised
Founded20172014
Note: one or both providers offer compounded medications for some services. Compounded medications are not FDA-approved.

Data as of July 19, 2026. Scores are editorial opinions reflecting documented business practices, transparency, pricing, access, and nonclinical consumer-service factors — not clinical quality or outcomes. Found an error? Report it →